Skip to Content

Travatan Z Approval History

FDA Approved: Yes (First approved September 21, 2006)
Brand name: Travatan Z
Generic name: travoprost
Dosage form: Ophthalmic Solution
Company: Alcon, Inc.
Treatment for: Glaucoma

Travatan Z (travoprost) is a new formulation of Travatan solution in which benzalkonium chloride is replaced with Sofzia, a robust ionic buffered preservative system that is gentle to the ocular surface. Travatan Z is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, who are intolerant of or insufficiently responsive to other intraocular pressure lowering medications.

Development History and FDA Approval Process for Travatan Z

DateArticle
Sep 21, 2006Approval Travatan Z Alcon, Inc. - Treatment for Glaucoma and Ocular Hypertension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide